| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |